Homeopathy as a Protective Factor to Covid-19

Phase 2

• Conditions: Coronavirus Infections; Homeopathy; Disease prevention; C01.925.782.600.550.200; SP2.026

• Registration Number: RBR-84nk5q6
• Lead Sponsor: niversidade Federal de Mato Grosso do Sul

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2021-02-28
• Study Start: 2021-05-20
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruitment completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Both sex; age over 18 and under 80 years; person not using other drugs prophylactically for the disease; absence of nonspecific respiratory syndrome in the last 14 days; no living with confirmed case of COVID-19; no positive test to RTP PCR-Covid-19.

Exclusion Criteria

Under 18 and or over 80 years; respiratory syndrome in the last 14 days; Positive test to COVID-19; use other preventive drugs to COVID-19; living with a confirmed case of COVID-19.

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence of severe case of COVID-19 in the period between 15 days and up to 03 months from the first medication intake.

Secondary Outcome Measures

Name	Time	Method
Incidence of serious adverse events (drug safety).